A new approach in ophthalmology that offers a revolutionary alternative to corneal transplantation has just been developed by researchers and clinicians in North America, Europe, and Oceania.
For patients with brain arteriovenous malformations, not having surgery or getting radiation therapy can result in an almost 70-per-cent lower risk of having a stroke or dying, reseachers find.
With a new study on re-using cardiac medical devices, the eldest son of two UdeM health professionals becomes the youngest author ever published in one of the world’s top medical journals.
A new test developed at CHU Sainte-Justine will enable better management of patients with severe combined immunodeficiency (SCID).
By depositing a saliva sample on a tiny device attached to your smartphone, you could find out in five minutes if you’re infected, say pharmacists at UdeM.
Three weeks after onset, more than 90% of infected people have antibodies that recognize one of the hallmarks of SARS-CoV-2, the S glycoprotein.
Université de Montréal researchers discover how a key cancer mutation activates telomerase, the ‘anti-aging enzyme’ that makes tumour cells immortal.
A cancer vaccine developed by the team headed by IRIC’s Dr. Claude Perreault is voted 2019 Scientific Discovery of the Year by the readers of Québec Science!
An international team led by an UdeM epidemiologist will seek to identify health systems on five continents that are best able to respond to the pandemic.
Quebec institutions are pooling their scientific expertise to develop an extraordinary immunization program using passive plasma to fight the disease.